Updated July 6, 2026

This week’s intelligence brief

Five forces shaping where humanity goes next: artificial intelligence, robotics, space, longevity, and the energy and compute powering them.

Artificial Intelligence

Anthropic Stacks Wins While China Chip Stocks Rally

Nobel laureate John Jumper is leaving Google DeepMind for Anthropic, whose Mythos model found vulnerabilities in classified US government systems and which launched Claude Tag inside Slack. Chinese AI stocks including Zhipu rallied on Beijing policy support, as Macquarie began coverage of five domestic chipmakers. Ford rehired 350 veteran engineers after AI fell short on manufacturing quality.

This week in AI

Robotics

Humanoids Hit Production As GM Automation Ignites Labor War

Hyundai will buy SoftBank's remaining 9.65% Boston Dynamics stake for $325 million as Atlas reaches production and delivered the World Cup ball before 80,000 fans. GM installed dozens of robot arms at its Detroit EV plant with 1,300 workers still laid off, drawing UAW opposition. NVIDIA launched Halos, a safety platform for human-adjacent robots.

This week in Robotics

Netflix for Robots Could Unlock US Manufacturing Revival, Bloomberg
GM installs robots at flagship EV factory after laying off 1,300 workers, Ars Technica
Hyundai to buy SoftBank's remaining stake in Boston Dynamics for $325 mln, newspaper says, Reuters
Meet the humanoid robot that just delivered the game ball at the Brazil v. Norway World Cup match, Fortune
Cockpit automation engine unveiled to minimize flight plan data errors, Interesting Engineering

Space

SpaceX's IPO Round Trip Resets Space Valuations

SpaceX's post-IPO rally reversed sharply, erasing roughly $600 billion in value as shares stabilized near $156 after a 16% one-day drop, briefly pushing Musk's net worth below $1 trillion to about $957 billion. SpaceX also added billions in new debt while cutting interest costs, prepared a Falcon 9 test of its Starfall cargo reentry vehicle, and Firefly Aerospace neared a $110 million EXIM loan.

This week in Space

Musk's SpaceX Adds Billions in Debt While Cutting Interest Costs, Bloomberg
The Tech Sell-off Goes Global, The New York Times
SpaceX drops more than 2% following $400 billion selloff, CNBC
With Starfall, SpaceX eyes an edge in global cargo delivery from orbit, Ars Technica
Firefly Aerospace expected to secure $110 million US EXIM loan, document shows, Reuters

Longevity

Capital Splits From Clinical Reality In Longevity Biotech

uniQure priced an upsized $225 million gene therapy offering on Nasdaq, while Elicio Therapeutics fell roughly 73% after its pancreatic cancer therapy missed a mid-stage endpoint, leaving about $15 million through Q4 2026. A Delaware jury ordered Amgen's Teneobio to pay Harbour Antibodies $20.2 million. Argentina repealed biotech patent restrictions, and Nvidia pitched agentic AI at Bio International.

This week in Longevity

A Biotech Wall Around China Would Come at a Cost, Bloomberg
Argentina loosens restrictions for biotech patents, says cabinet chief, Reuters
Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal, Reuters
Amgen owes $20.2 million in antibody patent lawsuit, US jury says, Reuters
Nvidia bets on agentic AI to turbocharge biotech discovery, SiliconANGLE News

Energy & Compute

Memory And Sovereign Compute Become AI's Next Bottlenecks

South Korea is negotiating with Samsung and SK Hynix to pull chip fab construction forward by over a decade to 2034-2035. Nvidia-backed Firmus will build a 360MW campus in Batam, Indonesia with 170,000 Nvidia chips and up to $30 billion in offtake through six years. Abu Dhabi's MGX is weighing a multi-billion-dollar acquisition of DayOne, while Wall Street tags Micron as the next Nvidia.